NANOGEN Biopharma is a leading innovative biotech company in the region. We utilize advance genetic engineering techniques for producing therapeutic recombinant proteins, humanized monoclonal antibody, and gene therapy products at a very affordable price.

Our Human health products include generic and branded biopharmaceutical produced in a strictly control environment that met WHO GMP Standards. We ready to supply finish products and raw material for domestic and international market.

We also offer advance biotechnology products for agriculture including Aquaculture and Livestock farming. Our products and technology helping the customers to reach sustainable practice and with increase profit margin. We have complete line of products for low cost organic Farming, and replacing the use of antibiotic.

Technology Transfer is available for therapeutic recombinant proteins, humanized monoclonal antibody with complete turnkey process equipment and instrument from upstream to dowstream processing.


We are specialized in production of recombinant proteins for therapeutic biopharmaceutical.
We have Interferons, Erythropoeitin, Humanized monoclonal antibody, Human Growth factor, Alteplase for Myocardial Infarction...
OEM Service: No  
No. of R&D Staff:
Estimated Annual Sales (USD): US$50 Million - US$100 Million  
Export Percentage:
Quality Control:
Legal Representative/CEO:
Factory Size (Sq.meters):
Factory Location:
Corporate Status: Corporation/Limited Liability Company  

Business Type: Year Established: 1997 Number of Employees: Legal Representative / CEO: Dr. Ho Nhan   Website: http://www.nanogenpharma.com Certificates: Brands: Trade & Market Main Markets: Main Customers: Export Percentage: Trade Shows: Factory Information Factory Size (Sq.meters): Factory Location: QA/QC: Number of Production Lines: Number of R&D Staff: Contract Manufacturing: